Clinical Trial Update: Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Adebrelimab with bevacizumab and albumin paclitaxel in non-squamous non-small cell lung cancer after first-line treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Albumin-bound paclitaxel (nab-paclitaxel)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Xiaorong Dong | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN